Manila Times Business
Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development
Oversubscribed Series B financing co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all existing investorsProceeds to support clinical development of lead first-in-class program ONA-255 in breast cancer, toward clinical proof of concept, and advance ONA-389 in colorectal cancerFinancing supports Ona’s transition to a clinical-stage company and delivery of key clinical and regulatory milestones
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Asset Workflows Appointed to NHS LPP Framework to Support Improved Asset Visibility and Utilisation Across the NHS
Just now
Realkredit Danmark A/S publishes new Base Prospectus for mortgage covered bonds and mortgage bonds
Just now
Sportradar Nets Official Wimbledon Tennis Data and AV Betting Rights Deal
Just now
Javier Bardem terrifies Amy Adams in TV adaptation of 'Cape Fear'
Just now